Inappropriate gonadotropin secretion in polycystic ovary syndrome
Objective To evaluate inappropriate gonadotropin secretion in women with polycystic ovary syndrome (PCOS). Design Retrospective study. Setting Academic tertiary center. Patient(s) A total of 373 women were classified into three groups: [1] healthy control women (n = 48); [2] women who were positive...
Gespeichert in:
Veröffentlicht in: | Fertility and sterility 2009-04, Vol.91 (4), p.1168-1174 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective To evaluate inappropriate gonadotropin secretion in women with polycystic ovary syndrome (PCOS). Design Retrospective study. Setting Academic tertiary center. Patient(s) A total of 373 women were classified into three groups: [1] healthy control women (n = 48); [2] women who were positive for PCOS risk factor; and [3] women with PCOS (n = 251). Intervention(s) None. Main Outcome Measure(s) Gonadotropin levels, LH-FSH ratio, body mass index, and clinical and/or biochemical presentations of PCOS. Result(s) The area under the receiver operating characteristic curve, used to predict PCOS for the LH-FSH ratio, showed similar diagnostic performance to total T and average ovarian volume. The LH-FSH ratio exhibits greater observed accuracy than total T and average ovarian volume for evaluation of women with oligomenorrhea or anovulation. An LH-FSH ratio of >1 presented the best combination of sensitivity and specificity. Body mass index was positively correlated with total T in non-PCOS and PCOS groups; however, body mass index was negatively correlated with LH in PCOS but showed no correlation in non-PCOS subjects. Conclusion(s) The LH-FSH ratio is a valuable diagnostic tool in evaluating women with PCOS and oligomenorrhea or anovulation, and an LH-FSH ratio of >1 may be used as a decision threshold. The link between body mass index and LH may provide clues for further understanding the pathological milieu of PCOS. |
---|---|
ISSN: | 0015-0282 1556-5653 |
DOI: | 10.1016/j.fertnstert.2008.01.036 |